TheNewswireWed, 15 Apr 2026 13:10:00 GMTLexaria's New Animal Study Aims to Expand Valuable Intellectual PropertyLEXX+0.98%
TheNewswireTue, 07 Apr 2026 13:10:00 GMTLexaria Applauds Eli Lilly's Foundayo(TM) Drug ApprovalLEXX+0.98%
TheNewswireThu, 26 Mar 2026 13:20:00 GMTLexaria's Robust Patent Portfolio Continues to GrowLEXX+0.98%
TheNewswireTue, 24 Mar 2026 13:15:00 GMTLexaria's Oral GLP-1 Drug Strategy Validated by IndustryLEXX+0.98%